FDA Approves Gene Therapy Tested In Boston To Treat Adults With Lymphoma
TRENTON, N.J. (CBS/AP) — U.S. regulators on Wednesday approved a second gene therapy for a blood cancer, a one-time, custom-made treatment for aggressive lymphoma in adults.
The Food and Drug Administration allowed sales of the treatment from Kite Pharma. It uses the same technology, called CAR-T, as the first gene therapy approved in the U.S. in August, a treatment for childhood leukemia from Novartis Pharmaceuticals.
That Novartis treatment was tested in Boston. In those tests, Dana Farber and Brigham and Women’s Hospital cancer researchers found that 80 percent of lymphoma patients who underwent the treatment we...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - October 19, 2017 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health Healthwatch Local News blood cancer Brigham and Women's Hospital Dana Farber FDA Gene Therapy Novartis Pharmaceuticals Source Type: news
Nigeria: Nigerian Doctor, Donald Nwosu Battles Deadly Cancer
[This Day] As public health physician, Donald Nwosu battles a rare type of cancer, Non-Hodgkins Lymphoma, Martins Ifijeh chronicles his fight to overcome the deadly disease, adding that he urgently needs help in order to survive it (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - July 20, 2017 Category: African Health Source Type: news
This 11-Year-Old Is One Of The Youngest Certified Yoga Teachers In America
Tabay Atkins is one of the youngest certified yoga instructors in the country. He received the first of his four yoga certifications just a week before his 11th birthday last August.
HuffPost spoke Wednesday with Tabay and his mom, Sahel Anvarinejad, whose battle with cancer first inspired Tabay to get involved with the practice.
Tabay, who is currently on a working vacay in Maui, Hawaii, with his family, was just 6 years old when his mother was diagnosed with Non-Hodgkin’s lymphoma.
In 2012, just two weeks after Anvarinejad’s recovery from the disease ― which hampered her ability to walk, among o...
Source: Healthy Living - The Huffington Post - June 22, 2017 Category: Consumer Health News Source Type: news
Latest Keytruda Approval Promising for Mesothelioma Patients
The U.S. Food and Drug Administration (FDA) expanded its approval of pembrolizumab for first-line treatment of metastatic non-small cell lung cancer last week, moving it closer to becoming a viable treatment option for patients with pleural mesothelioma.
Pembrolizumab is marketed by Merck & Co. under the brand name Keytruda.
It helps the body’s immune system detect and destroy cancer cells.
The FDA approved its first-line use in combination with pemetrexed and carboplatin, two chemotherapy agents used regularly for mesothelioma.
Pembrolizumab, the most well-known immunotherapy drug, is being studied for use with var...
Source: Asbestos and Mesothelioma News - May 19, 2017 Category: Environmental Health Authors: Matt Mauney Tags: carboplatin chemotherapy for mesothelioma Dr. Raymond Wong Dr. Tawee Tanvetyanon FDA approval Keytruda first line treatment for mesothelioma Hodgkin lymphoma jimmy carter keytruda clinical trial keytruda for mesothelioma melanoma Mer Source Type: news
Moms Exposed To Monsanto Weed Killer Means Bad Outcomes For Babies
Concerns about the world’s most widely used herbicide are taking a new twist as researchers unveil data that indicates pervasive use of Monsanto Co.’s weed killer could be linked to pregnancy problems.
Researchers looking at exposure to the herbicide known as glyphosate, the key ingredient in Monsanto’s Roundup-branded herbicides, said they tested and tracked 69 expectant mothers and found that the presence of glyphosate levels in their bodily fluids correlated with unfavorable birth outcomes. The research is still in preliminary stages and the sample size is small, but the team is scheduled to present th...
Source: Healthy Living - The Huffington Post - April 4, 2017 Category: Consumer Health News Source Type: news
Spencer gets back on the court after cancer
For much of his 17 years, Spencer Riley has lived to play basketball. This winter, his favorite sport helped the teenager get back to life.
Riley was diagnosed with non-Hodgkin lymphoma in 2016 and treated at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center that summer. He underwent an intensive three-month treatment cycle: one week of inpatient chemotherapy at Boston Children’s Hospital, two weeks of recuperation at home, and then back to Boston Children’s.
While occasionally well enough to go on family outings, he was still too weak to shoot or even dribble a basketball.
But the game was never far fr...
Source: Thrive, Children's Hospital Boston - March 29, 2017 Category: Pediatrics Authors: Saul Wisnia Tags: Diseases & Conditions Our Patients’ Stories Dana-Farber/Boston Children's Cancer and Blood Disorders Center Dr. Dan Benedetti non-Hodgkin lymphoma Source Type: news
ICR study reports Hodgkin lymphoma survivors at high risk of second cancers
A new study conducted by UK-based Institute of Cancer Research (ICR) has revealed that Hodgkin lymphoma survivors are at high risk of developing a second type of cancer, especially if they have a family history of the disease. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - March 14, 2017 Category: Pharmaceuticals Source Type: news
Hodgkin Lymphoma Survivors Face Risk of Second Cancer
Those diagnosed at younger age or have a family history of cancer even more vulnerable
Source: HealthDay
Related MedlinePlus Page: Hodgkin Disease (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - March 13, 2017 Category: Consumer Health News Source Type: news
Hodgkin lymphoma survivors at high risk of second cancers
Patients who are cured of Hodgkin lymphoma are at a high risk of developing a second type of cancer, particularly if they have a family history of the disease, a major new study reports. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - March 13, 2017 Category: Science Source Type: news
Hodgkin lymphoma survivors at high risk of second cancers
(Institute of Cancer Research) Patients who are cured of Hodgkin lymphoma are at a high risk of developing a second type of cancer, particularly if they have a family history of the disease, a major new study reports. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 13, 2017 Category: Cancer & Oncology Source Type: news
UNC Lineberger launches innovative cellular immunotherapy program
(UNC Lineberger Comprehensive Cancer Center) UNC Lineberger Comprehensive Cancer Center has opened two cellular immunotherapy trials. The early-stage CAR-T trials are for patients with either Hodgkin lymphoma or non-Hodgkin lymphoma, who lack other treatment options or are at high risk of their disease returning. Researchers are working to open trials for other cancers. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 28, 2017 Category: Global & Universal Source Type: news
Africa: Hodgkin's Lymphoma - an Uncommon Cancer That's Easily Missed in Africa
[The Conversation Africa] Hodgkin's lymphoma is an uncommon cancer that targets the immune system. It starts off as a painless swelling in the neck, armpit or groin. The Conversation Africa's health editor Joy Wanja Muraya asked Professor Nicholas Abinya to explain the disease, its stages of development and treatment. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - February 17, 2017 Category: African Health Source Type: news
Veterans Exposed To Contaminated Water At Marine Base To Receive Disability Benefits
WASHINGTON, Jan 12 (Reuters) - The Obama administration has agreed to provide disability benefits to military veterans exposed to contaminated drinking water while at Camp Lejeune in North Carolina, according to an official notice published on Thursday.
Veterans, former reservists and former National Guard members who served for at least 30 days at the U.S. Marine Corps Base from 1953 to 1987 and have been diagnosed with one of eight diseases are eligible, according to the document published in the Federal Register, the government’s official journal.
The Associated Press, which first reported the story, said the esti...
Source: Healthy Living - The Huffington Post - January 13, 2017 Category: Consumer Health News Source Type: news
VA ’s Rule Establishes a Presumption of Service Connection for Diseases Associated with Exposure to Contaminants in the Water Supply at Camp Lejeune
The U.S. Department of Veterans Affairs (VA) announced that it has established a presumption of service connection for eight diseases that may be associated with exposure to contamination in the water supply at Camp Lejeune in North Carolina from August 1, 1953 to December 31, 1987. This will make it easier for veterans to receive the care and benefits they need. The eight diseases are adult leukemia, aplastic anemia and other myelodysplatic syndromes, bladder, kidney, or liver cancer, multiple myeloma, non-Hodgkin's lymphoma, and Parkinson's disease. (Source: News stories via the Rural Assistance Center)
Source: News stories via the Rural Assistance Center - January 13, 2017 Category: Rural Health Source Type: news
Cancer Facts and Figures: Death Rate Down 25% Since 1991
By Stacy Simon The death rate from cancer in the US has declined steadily over the past 2 decades, according to annual statistics reporting from the American Cancer Society. The cancer death rate for men and women combined fell 25% from its peak in 1991 to 2014, the most recent year for which data are available. This decline translates to more than 2.1 million deaths averted during this time period. “Cancer Statistics, 2017,” published in the American Cancer Society’s journal CA: A Cancer Journal for Clinicians, estimates the numbers of new cancer cases and deaths expected in the US this year. The estimat...
Source: American Cancer Society :: News and Features - January 5, 2017 Category: Cancer & Oncology Tags: General Information Source Type: news
